Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calypso Medical Technologies is a medical device company that developed the Calypso System, a real-time tracking technology for radiation therapy often referred to as "GPS for the Body." The system uses implanted electromagnetic transponders to provide continuous, objective information on the location of a tumor during radiation treatment. This precision allows for tighter treatment margins, enabling clinicians to deliver higher doses of radiation to the target while sparing surrounding healthy tissue. Primarily utilized for prostate cancer, the technology was later expanded to include applications for lung cancer. The company was acquired by Varian Medical Systems in 2011 to bolster their image-guided radiation therapy portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calypso Medical.